Skip to main content
Fig. 2 | Journal of Medical Case Reports

Fig. 2

From: Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports

Fig. 2

Clinical course of case 2. Axial CT images corresponding to the timelines of therapy and disease status. Red circles indicate the lung and hilar metastatic lesions. a (top) Status during administration of docetaxel (DTX). b Progression of lung metastasis before treatment with adoptive cell therapy (ACT). c Regression of lung metastasis after treatment with ACT and dendritic cell (DC) vaccine. d Progression of lung and hilar lymph node metastases before administration of nivolumab. e Regression of lung metastasis 8 weeks after immune checkpoint inhibitor (ICI) and ACT combination treatment. Responses were durable during maintenance therapy with the ICI (f). Narrow black arrows, bold black arrows, and red arrows indicate ACT, DC vaccine, and nivolumab administration, respectively (bottom)

Back to article page